Tang Q. et al. (2023) investigated the immunomodulatory and anti-inflammatory properties of Embelin in LPS- induced AKI, revealing that Embelin can mitigate AKI by inhibiting M1 macrophage activation and blocking NF-κB signaling in mice. The gene discussed is NFKB1; the disease is acute kidney injury.